CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (Q64673567)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer |
clinical trial |
Statements
CY503C2 (English)
0 references
Phase II Double-blind Placebo-controlled Trial of CY503 in Patients With Chemotherapy-refractory Metastatic Colorectal Cancer (English)
0 references
July 2009
0 references
August 2012
0 references
77
0 references
18 year
0 references